SAN DIEGO, Aug. 30, 2004 LAWFUEL – Best for law, law news, legal news, legal articles Cooley Godward LLP was named the most active IPO issuer’s law firm nationwide for completed IPOs in the past 12 months, as reported in the recently released IPO Vital Signs analysis. The law firm represented 13 IPO issuers who raised a total of $863 million.
“Cooley’s leadership in IPO transaction work is due to our diverse client base,” said Kenn Guernsey, a partner in Cooley Godward’s Business Department. “We are fortunate to have a great group of corporate clients that weathered the downturn well and came out the other end ready to hit the IPO window when it opened.”
Cooley advised the following IPO issuers:
ACADIA Pharmaceuticals, Inc. $35 million
Anadys Pharmaceuticals, Inc. $43.8 million
Blue Nile, Inc. $78 million
Corgentech Inc. $96 million
Genitope Corporation $33.3 million
GTx, Inc. $78.3 million
Gladstone Commercial Corporation $99 million
iPass Inc. $98 million
Leadis Technology, Inc. $84 million
Mannkind Corporation $77 million
Metabasis Therapeutics, Inc. $35 million
Myogen, Inc. $70 million
Senomyx, Inc. $36 million
IPO Vital Signs tracks and reports on IPO statistics and trends for use by pre-IPO companies and IPO professionals. For more information, visit www.ipovitalsigns.com.
Cooley Godward LLP is an established provider of strategic litigation and business transaction services, and a recognized leader in the representation of high-growth private and public companies, venture capital firms and nonprofit organizations. Founded in 1920, Cooley Godward has five offices nationwide with affiliates throughout Europe and Asia. For additional information: www.cooley.com.
